Allergan receives 2016 ENERGY STAR Partner of the Year Award from US Environmental Protection Agency
Company recognized with ENERGY STAR Award for fifth time.
Allergan has received an ENERGY STAR 2016 Partner of the Year — Sustained Excellence Award from the US Environmental Protection Agency (EPA) for its continued improvement of energy performance and leadership in energy management in both the pharmaceutical and industrial sectors.
Allergan has been an ENERGY STAR partner since 1996 and recognized by the EPA for the fifth time. The 2016 Partner of the Year — Sustained Excellence Awards are presented to organizations recognizing their contributions to reducing harmful carbon pollution through superior energy efficiency efforts. These awards recognize ongoing leadership in the ENERGY STAR program.
"By continued collaboration with ENERGY STAR, Allergan is helping Americans save money, save energy, and do their part to reduce our nation's greenhouse gas emissions that exacerbate climate change," said EPA Administrator Gina McCarthy. "I'm proud to recognize Allergan with the highest form of ENERGY STAR recognition, as the winner of the 2016 Partner of the Year — Sustained Excellence Award. Allergan demonstrates a strong commitment to energy efficiency and to preserving a healthy planet for future generations."
The award also recognizes four Allergan manufacturing sites that have achieved ENERGY STAR rankings in the top 25% of pharmaceutical plant energy performance nationwide: Waco, Texas for eight consecutive years, and first time awards for Cincinnati, Ohio; Fajardo, Puerto Rico; and Manati, Puerto Rico. Also achieving ENERGY STAR certification this year were five buildings at the Allergan campus in Irvine, CA.
"Allergan has a long history and commitment to improving our energy performance and reducing our impact on the environment, and we are proud to be recognized by ENERGY STAR for our efforts," said Wayne Swanton, Senior Vice President, Global Operations at Allergan. "Our partnership with ENERGY STAR is part of our ongoing commitment to the environment, including using greener sources of energy and reducing greenhouse gas emissions within our operations."
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance